WebMar 30, 2016 · Xiaotian Dai, Principal Investigator, Regend Therapeutics: ClinicalTrials.gov Identifier: NCT02722642 Other Study ID Numbers: 201602301 : First Posted: March 30, 2016 Key Record Dates: Last Update Posted: March 18, 2024 Last Verified: March 2024 Individual Participant Data (IPD) Sharing Statement: WebNo New Molecular Entity No Highest Development Phases Preclinical Bacterial infections …
Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, …
WebFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports … WebDec 20, 2024 · Idiopathic pulmonary fibrosis (IPF) is a serious chronic (long term) disease … free apps for block games
Exceptionally Robust Asthma Pipeline with More Than 100+
Web6 Mutationen in Hämöglobingenen, neue Fallstudie zu Thalassämien Kapitel 13: neue Fallstudie zu Proteinkinase-A-Mutationen und Cushing Syndrom Kapitel 14: erweiterte Darstellung zu WebJun 13, 2024 · Principal Investigator: Xiaotian Dai, principal investigator – Regend Therapeutics Citations Reporting on Results Zuo W, Zhang T, Wu DZ, Guan SP, Liew AA, Yamamoto Y, Wang X, Lim SJ, Vincent M, Lessard M, Crum CP, Xian W, McKeon F. p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. WebJun 22, 2024 · Therapeutics Assessment By Mechanism of Action: ... Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, ... free apps for cartoons